Clinical Trial Update: Quantifying Musical Performance After Treatment With Myobloc in Musician's Dystonia [Phase 4]

View source ↗

Summary

This Phase 4 study from Columbia University evaluated musical performance after treatment with rimabotulinumtoxinB (Myobloc) in musicians with focal dystonia; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Dystonia
• Musician Dystonia

Drugs mentioned

• MYOBLOC (rimabotulinumtoxinB)

Snippet

Sponsor: Columbia University | Conditions: Focal Dystonia | Phase 4 | Status: COMPLETED | Results posted: 2014-05-09